TEMU ILMIAH PENYAKIT DALAM 2020

JADWAL WORKSHOP
From Symptom And Sign To Comphrehensive Treatment In Covid 19
Kamis, 29 Oktober 2020

Waktu PROGRAM
Re - registrasi
Pembukaan
WORKSHOP 1
Dyslipidemia
PT. Mitsubishi Tanabe Pharma Indonesia
Moderator: dr. Rukiah Chodilawati, SpPD, K-KV
07.30 – 08.00 Addresing Challenge of Dyslipidemia in Cardio Metabolic
(dr. Ferry Usnizar, SpPD, KKV)
08.00 – 08.30 Addresing Challenge of Dyslipidemia in ASCVD
(DR. dr. Taufik Indrajaya, SpPD, KKV)

08.30 – 09.45 Diskusi kasus

09.45 – 10.00 Post test

WORKSHOP 2
Hipertensi Emergency
PT. Mitsubishi Tanabe Pharma Indonesia
Moderator : dr. Suprapti, SpPD, K-GH
10.00 - 10.30 Hypertension Emergency Management
(DR. dr. Zulkhair Ali, SpPD, KGH)
10.30 – 11.00 The Role of Non Dihidropiridine CCB for Hypertension Emergency Management
in Daily Practice
(dr. Novadian, SpPD, KGH)

11.00 – 12.15 Diskusi kasus

12.15 – 12.30 Post test

WORKSHOP 3
Elektrocardiografi
Moderator:dr. Erwin Azmar, SpPD, KKV
12.30 – 13.00 ECG  Electrolyte imbalance dan Block
(dr. Erwin Sukandi, SpPD, KKV)
13.00 – 13.30 ECG : Aritmia supraventrikel dan Myocard infarct
(dr. Imran Saleh, SpPD, KKV)
13.30 – 14.45 Diskusi kasus

14.45 – 15.00 Post test

WORKSHOP 4
Terapi Cairan
PT. KALBE
Moderator: Dr. Rouly Pasaribu, SpPD, KP
15.00 – 15.30 Nutritional Therapy : Everything You Have to Know
(dr. Mediarty Syahrir, SpPD, KHOM)
15.30 – 16.00 The Importance of Fluid Therapy in Hospital
(dr, Suprapti, SpPD, KGH)

16.00 – 17.15 Diskusi Kasus

17.15 – 17.30 Post test

 TEMU ILMIAH PENYAKIT DALAM 2020
JADWAL SYMPOSIUM
From Symptom And Sign To Comphrehensive Treatment In Covid 19
Jumat, 30 Oktober 2020

Waktu PROGRAM
07.30-08.00 Pembukaan (Vidio)
Durasi 5 Menit atau 15 Menit
08.00-08.30 PLENARY LACTURE
COVID 19
Moderator: dr. Ahmad Rasyid, SpPD, K-P
Speaker: dr. Zen Achmad, SpPD, KP
SIMPOSIUM 1
Chronic Liver Disease
Moderator: dr. Ayus Astoni, SpPD, K-GEH
08.35.08.55 Liver injury in covid 19 --> Biolife
(dr. A. Fuad Bachry, SpPD, KGEH)
08.55-09.15 Comprehensive Management of Chronic Liver Disease (The Role of
Hishiphagen )--> Darya Varia
09.15-09.35 (dr. Syadra Bardiman, SpPD, KGEH)
the role of albumin in Decompensated Cirrhosis ; new concept and perspective 
PT. DIPA.
(dr. Suyata, SpPD, KGEH)

09.35-10.00 Diskusi
SIMPOSIUM 2
Autoimmun and Covid 19
PT. NOVARTIS
Moderator: Prof. Dr. Eddy Mart Salim, SpPD, KAI
10.05-10.25 Autoimmun and Covid 19: What need to know?
(dr. Nova Kurniati, SpPD, KAI)
10.25-10.45 SLE vs other autoimmun deasese: What’s the different?
(dr. Yuniza, SpPD, KAI)

10.45-11.30 Diskusi
11.30-13.00 SHOLAT JUMAT
SIMPOSIUM 3
The importance of blood pressure and blood glucose controlled during Covid 19
pandemic
Moderator : dr. Alwi Shahab, SpPD, K-EMD
13.00-13.20 Greater importance of blood glucose control for T2DM patients
 (dr. Ratna Maila Dewi, SpPD, KEMD)
13.20-13.40 Benefit of SPC ARB treatment in hypertension and controversies during the
Corona Pandemic (COVID-19)
(dr. Erwin Azmar, SpPD, KKV)
13.40-14.00 Covid-19 and Diabetes Mellitus: Implications for Clinical Management and
Prognosis BD
(dr. Yulianto Kusnadi, SpPD, KEMD)

14.00-14.30 Diskusi
SIMPOSIUM 4
Prediabetes & Type 2 Diabetes Mellitus and Thyroid Disorders
PT. MERCK
Moderator: Dr. Erwin Sukandi, SpPD, K-KV
14.30-14.50 Pre DM: Optimizing Prediabetes Management with Metformin
(dr. Yulianto Kusnadi, SpPD, KEMD)
14.50-15.10 FDC: Can Technology of Glibenclamide Help the Patient with Type 2 Diabetes
Mellitus?
(dr. Alwi Shahab, SpPD, KEMD)
15.10-15.30 When to Start and How to Maintain Thyroid Disorders Treatment
(dr. Ratna Maila Dewi Anggraini, SpPD, KEMD)

15.30-16.00 Diskusi
 TEMU ILMIAH PENYAKIT DALAM 2020
JADWAL SIMPOSIUM
From Symptom And Sign To Comphrehensive Treatment In Covid 19
Sabtu, 31 Oktober 2020

Waktu PROGRAM
SIMPOSIUM 5 --> Abbott
Update of Malnutrition Risk Assesment and Intervention: New Evidence
Based of HMB to Improve Patient Outcome
Moderator: dr. Djunaidi AR, SpPD
07.30 – 07.40 Pembukaan

07.40 – 08.00 Update on Malnutrisi Risk Assesment and Intervention

(dr. Nur Riviati, SpPD K-Ger)
08.00– 08.40 New Evidence Based of ONS with HMB to Improve Patient’s Outcome
(DR. dr. Chezeresna Heriawan Soejono, SpPD, K-Ger)

08.40 - 09.00 Product Presentation

09.00 – 09.30 Diskusi

SIMPOSIUM 6
ITP and Hematology Disorder
Moderator: dr. Indriyani Hermiyana, SpPD, K-HOM
09.30 – 09.50 Clinical Diagnosis and Phatophysiology of Cronic ITP  Novartis
(dr. Yenny dian Andayani,SpPD, K-HOM)
09.50 – 10.10 The Role of Eltrombopag in Comprehensive Management of Chronic ITP -->
Novartis
(dr. Mediarty, SpPD, K-HOM)
09.10 – 10.30 Case Sharing Experience of Chronic ITP Patient Treated with Eltrombopag à
Novartis
(dr. Norman Djamaludin, SpPD, K-HOM)

10.30 -11.00 Diskusi

SIMPOSIUM 7
GI Tract Bleeding
Moderator: Dr. Anjab Akmal Sya;roni, SpPD
11.00 – 11.20 Comprehensive management of GI Tract Bleeding in severe COVID 19 patient--
> PT. ASTRAZENECA
(dr. Vidi Orba Busro, SpPD, KGEH)
11.20 – 11.40 The Role of Terlipine in Management of GI Tract Bleeding --> PT. DEXA
(dr. Syadra Bardiman, SpPD K-GEH)
11.40 – 12.30 Diskusi
SIMPOSIUM 8
COPD and Asma
Moderator: dr. RA Linda, SpPD, K-P
12.30 -12.50 COPD management - What type of patient benefits from ICS/LABA Therapy à
GSK
(dr. Zen Ahmad, SpPD, KP)
12.50 – 13.10 Importance on Consistency Use of ICS/LABA dosing in Asthma Control à GSK
(Prof. dr. Eddy Mart Salim, SpPD, KAI)
13.10 – 13.30 Nutrition of COPD patient --> Fresenius
(dr. Sudarto, SpPD, KP)

13.30 – 14.00 Diskusi

SIMPOSIUM 9
PT NOVO NORDISK
Moderator: dr. Surya Darma, SpPD
14.00 – 14.20 Challenges & Unmeet Need in T2DM Patient Needing Insulin: Do We Need
Innovation ?
(dr Alwi Shahab, SpPD, K-EMD)
14.20 – 14.40 Take a Look at Insulin Degludec
(dr. RM Dewi, SpPD, KEMD)
14.40 – 15.00 Introducing Ideg Asp Co Formulation Insulin
(dr. Yulianto Kusnadi, SpPD, K-EMD)

15.00 – 15.30 Diskusi

SIMPOSIUM 10 
Moderator: dr. Nelda Aprilia Salim, SpPD
15.30 -15.50 Comprehensive management therapy of Thyroid : focus on hipo & hiperthyroid
 Novell
(dr. Yulianto Kusnadi, SpPD, K-EMD)
15.50. 16.10 Beyond the Standart of T2D Management : CHAT Perspective  Boehringer
(dr Alwi Shahab, SpPD, K-EMD)

16.10 – 17.00 Diskusi

 TEMU ILMIAH PENYAKIT DALAM 2020
JADWAL SIMPOSIUM
From Symptom And Sign To Comphrehensive Treatment In Covid 19
Minggu, 1 November 2020

Waktu PROGRAM
SIMPOSIUM 11
Chronic kidney disease in covid 19
Moderator: Dr. Suprapti, SpPD, K-GH
09.00-09.20 Management of Anemia in Chronic Kidney disease PT. Etana
(dr. Novadian, SpPD KGH)
09.20-09.40 Iron therapy in Patients with Renal Failure
(dr. Ian Effendi, SpPD, K-GH)
09.40-10.00 Covid and Kidney Disease Novell
(DR.dr. Zulkhair Ali, SpPD, K-GH)

10.00-10.30 Diskusi
SIMPOSIUM 12
Dyspepsia and IBS
Moderator: Dr. Mega Permata, SpPD, K-PTI
10.35-10.55 Breakthrough in the management of IBS-C and CIC: The Role of Lubiprostone
PT. Takeda
(dr. Imam Suprianto, SpPD, K-GEH)
10.55-11.15 Focus on Management of GERD in Daily Practice PT. Eisai
(dr. Vidi Orba Busro, SpPD, KGEH)
11.15-11.35 Psychosomatic aspect of fungtional Dyspepsia
(dr. M. Ali Apriansyah, SpPD, KPsi)

11.35-12.00 Diskusi
SIMPOSIUM 13
Moderator: Prof. dr. Ali Ghanie,SpPD, K-KV
12.30 -12.50 Hypertrigliseridemia and the Risk Cardiovascular Event  Darya Varia
(dr. Syamsu Indra, SpPD, K-KV)
12.50 – 13.10 "Implementation of Dyslipidemia Guideline in clinical practice, Role of 3rd
Generation Water Soluble Statin PT. AstraZeneca
(dr. Erwin Sukandi, SpPD, KKV)
13.10 -13.30 Taming the Metabolic Omnivore : Optimize Treatment in Diabetic Patient with
Chronic Coronary Syndrome Servier
(DR. dr. Taufik Indrajaya, SpPD, K-KV)

13.30 – 14.00 Diskusi

 SIMPOSIUM 14
Moderator: Dr. M. Reagan, SpPD
14.00 – 14.20 Review of antipyretic (Paracetamol or Ibuprofen?) in Covid-19 patient 
Fahrenheit
(dr. Harun Hudari, SpPD, K-PTI)
14.20 – 14.40 Management of Autoimun Diseases (SLE, RA, Sjogren Syndrome) With
Hydroxychloroquine Covid 19 Era
(dr. Surya Darma, SpPD)
14.40.15.00 Resign Update Gout Arthritis Management
(DR. dr. Radiyati Umi Partan, SpPD, K-R)

15.00 -15.30 Diskusi

SIMPOSIUM 15
Moderator: Dr. Mega Permata, SpPD, KPTI
15.30 -15.50 Use of pro-TB Therapy in Pulmonary Tuberculosis Patients  Phapros
(dr. Ahmad Rasyid, SpPD, KP)
15.50 -16.10 Nutrition in Pulmonary Tuberculosis  Kalbe
(dr. Rouly Pasaribu, SpPD, KP)
16.10. 16.30 Managing Cancer Patient During Covid-19: Supportive Care & Respiratory
Hyegene
(dr. Yenny Dian Andriani, SpPD, KHOM)
16.30. 16.45 Oral and Respiratory Hyegene as Additional Pretection to Prevent Cross
Infection of Covid-19: The Role of PVP-I &Lota Carrageenan
(dr. Rini Cendikia)

16.45. 17.00 Diskusi